‘People are trying to be creative’: Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loans

U.S. importers are waiting on an estimated $166 billion in tariff refunds after the Supreme Court struck down Trump-era IEEPA tariffs, but only 26,664 of more than 330,000 affected importers have signed up for CBP’s automated refund system, representing $120 billion of tariff revenue. With refunds potentially taking 45 days or longer and some companies facing cash চাপ, firms are using claims as loan collateral at roughly 50% loan-to-value or selling them for about 25% of projected value. The uncertainty is pressuring cash flow across manufacturing, automotive, retail, and consumer goods, and could drive more borrowing or distressed claim sales before refunds are distributed.

Analysis

The key market implication is not the refund itself but the financing gap it creates. A contingent receivable is being transformed into quasi-collateral, which effectively gives a distressed-credit wrapper to operating companies that were previously fine but now face working-capital stress; that pushes risk from trade policy into bank balance sheets, specialty lenders, and private-credit structures. The first-order winners are liquidity providers and claim buyers, but the second-order risk is that weaker importers use refund monetization to delay restructuring, which can prolong margin compression and keep inventory normalization messy for another 2-4 quarters.

This is especially relevant for retailers, auto suppliers, and consumer brands with thin cash conversion cycles. A 50% loan-to-value structure on uncertain reimbursement is economically similar to asset-based lending with a volatile collateral base, so spreads should widen for borrowers with tariff exposure even if headline default rates stay contained. If refund processing slips beyond the initial rollout window, financing costs can exceed the ultimate claim value, turning the receivable into a source of incremental losses rather than relief.

The contrarian point is that the market may be underestimating how many claims end up economically worthless or partially disallowed. That creates dispersion: larger, better-documented importers can arbitrage the process, while smaller suppliers may get forced into distressed sale prices or covenant breaches. The eventual refund headline is therefore less important than the operational burden and timing mismatch, which should favor firms with strong balance sheets and punish those using the proceeds to bridge near-term liquidity needs.

Near term, the catalyst is not legal news but cadence of actual disbursements versus promised timelines. If the refund system under-delivers in the first 30-45 days after launch, expect a step-up in private-credit demand, claim sales, and restructuring headlines. If it over-delivers, the relief should compress financing spreads quickly, but that upside is likely concentrated in a narrow set of stressed importers rather than the broader consumer complex.

Key Decisions for Investors

• Long BNPL/asset-based/private-credit lenders with proven specialty finance underwriting; avoid broad exposure to lower-quality import-dependent borrowers for the next 1-2 quarters.
• Short a basket of tariff-exposed, cash-constrained retailers and auto suppliers versus long high-quality industrials with pricing power; look for balance-sheet-sensitive names with negative FCF and high inventory days.
• Buy CDS protection or underweight lower-rated leveraged loans tied to import-heavy issuers; refund uncertainty is a hidden extension risk that can widen spreads even without immediate default.
• For event-driven trades, accumulate selective claim-purchase platforms and liquidation specialists on any processing delays; they benefit if distressed monetization activity accelerates over the next 60-90 days.
• Monitor bank earnings for rising usage of receivable-backed borrowing; if average advance rates stay near 50% but delays lengthen, reduce exposure to regional banks with concentrated ABL books.